Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →
North Carolina – Regional Life Sciences Roundup -October 23th, 2026 Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection […]
Read More →During DC Tech Startup Week, BioBuzz and PwC hosted Insights to Impact at PwC’s headquarters on October 13. Through WayFounder, we invited four Korean startups and their teams to join us. WayFounder is a cross-border accelerator and angel investor group based in Tysons Corner, Virginia. It works with international startups that are ready to enter, […]
Greater Philadelphia – Regional Life Sciences Roundup – October 29, 2026 Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated […]
Suvoda, a Conshohocken, Pennsylvania-based clinical trial technology company, has expanded Greenphire Travel, its software and services for managing patient travel to clinical trial visits, the company announced on October 28, 2026. The update adds rideshare access through Lyft, Uber Health, and Bolt, along with new tools for trial sites and sponsors. “Participants in clinical trials […]
Pennsylvania Governor Josh Shapiro has signed Senate Bill 381, known as the Beagle Bill, into law, creating an adoption pathway for dogs and cats once their use in research or testing ends, Humane World for Animals announced on October 23, 2026. The governor signed the bill on October 22. The law also bans the sale […]
MAXONA Pharmaceuticals, a privately held, Malvern, Pennsylvania-based clinical-stage drug developer, is moving closer to a new U.S. patent covering the use of nefopam to treat pruritus, or itch, the company announced on October 27, 2026. The U.S. Patent and Trademark Office (USPTO) has issued a notice of allowance for the company’s method-of-treatment application. MAXONA also […]
Ensemble Investments has announced the launch of KAAZI, a new workforce development and training center powered by Orchestra Life Sciences (OLS) at the Philadelphia Navy Yard. Located at 1200 Intrepid Avenue, the center will provide specialized training to prepare workers for careers in pharmaceutical and advanced therapy manufacturing, helping life sciences employers build the skilled […]
Avantor, a Radnor, Pennsylvania-based life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries, has appointed Mikey Santiago as Chief Information Officer, the company announced on October 26, 2026. Santiago brings more than two decades of technology leadership experience, including four CIO roles, and will […]
Aclaris Therapeutics, a Wayne, Pennsylvania-based clinical-stage biopharmaceutical company developing treatments for immuno-inflammatory diseases, has priced a public offering expected to raise about $50 million, the company announced on October 27, 2026. The same morning, Aclaris reported results from two Phase 1b proof-of-concept trials of ATI-052, its investigational bispecific antibody, in atopic dermatitis (AD) and asthma. […]
A new monthly discussion series from Blackbird Laboratories is bringing experienced biotech entrepreneurs, executives, scientists, and operators to Baltimore’s emerging life sciences community. The inaugural Blackbird Forum featured serial entrepreneur Nick Culbertson in conversation with Blackbird CEO Matt Tremblay, Ph.D., exploring the lessons behind building and scaling healthcare companies. Building a biotech company takes more […]
